Brokerage Firm Rating on PerkinElmer (PKI)

PerkinElmer (PKI) has an average broker rating of 2.58, which is interpreted as a Hold, as rated by 13 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 1 other analysts advise a Buy. Nevertheless, the majority of 8 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company.

PerkinElmer (PKI) : Average target price received by PerkinElmer (PKI) is $56.27 with an expected standard deviation of $3.32. The most aggressive target on the stock is $61, whereas the most downbeat target is $51. 11 financial analysts are currently covering the stock.


Company shares have received an average consensus rating of Hold for the current week PerkinElmer (NYSE:PKI): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $54.65 and $54.36 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $54.91. The buying momentum continued till the end and the stock did not give up its gains. It closed at $54.72, notching a gain of 0.33% for the day. The total traded volume was 323,669 . The stock had closed at $54.54 on the previous day.

In a related news,The director of Perkinelmer Inc, Michas Alexis P sold 1,953 shares at $54.85 on June 2, 2016. The Insider selling transaction had a total value worth of $107,122. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Companys Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and more accurately, and to accelerate the discovery and development of new therapies. The Companys Environmental Health segment provides products, services and solutions to facilitate the creation of safer food and consumer products, more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.